This protocol is judged by an institutional evaluation board, an unbiased team that reviews any scientific trials involving humans. If a research will involve a Timetable I drug, after the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) selection from the FDA.And Because the co